Domov › Nemalobunkový karcinóm pľúc › Kalifornia › Fullerton

Klinické štúdie Nemalobunkový karcinóm pľúc v meste Fullerton, CA

13 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Fullerton a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Prebieha náborFáza 1/2

Providence - St. Jude Medical Center /ID# 271414, Fullerton

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06772623

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Prebieha náborFáza 3

Providence St. Jude Medical Center ( Site 0106), Fullerton

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06623422

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Prebieha náborFáza 3

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center, Fullerton

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07144280

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Prebieha náborFáza 2

Providence Medical Foundation, Fullerton

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06667076

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Prebieha náborFáza 3

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
Providence St. Jude Medical Center, Fullerton
a 1 ďalších

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06758401

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Prebieha náborFáza 1/2

Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
Providence St. Jude Medical Center, Fullerton

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07227298